Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...

Explore the new AI model that links genetic mutations to disease outcomes, revolutionising genetic diagnosis and treatment.

A newly developed AI can predict which diseases specific genetic mutations are likely to cause, not just whether they are ...

Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at ...

AlphaFold didn't accelerate biology by running faster experiments. It changed the engineering assumptions behind protein ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. Jason Mast is a general assignment reporter at ...

A noninvasive AI tool may be able to predict potential cardiovascular events in patients with suspected stable coronary ...

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases. By Gina Kolata Gina Kolata has ...